To book your expert consultation, get in touch today!
CagriSema is a fixed-dose combination of cagrilintide (an amylin analogue) and semaglutide (a GLP-1 receptor agonist), and is currently (as of March 27, 2025) an experimental obesity drug developed by Novo Nordisk
Molecular dynamics studies Molecular Dynamics (MD) simulations were performed for the apo AlphaFold prepared structure of SLC25A45, as well as when in complex/docked to the ligand TML
This document includes the specific results from third-party HPLC and MS analyses, along with the batch number and manufacturing date, enabling complete lot traceability and confidence in your research materials
However, in toxic doses of paracetamol, the bodys glutathione stores become depleted, leading to the accumulation of NAPQI
Suzanne Luna, Certified Personal Trainer, and former collegiate gymnast is our bioTE coordinator and also assists Dr